NFKB1 and neoplasm: This tumor‐stroma interaction resulted in the activation of NF‐κB, MAPK, and Notch signaling pathways, immune and inflammatory responses associated with increased resistance of bTME+ BM‐NSCLC to afatinib compared to monocultures [89].